212 results
8-K
EX-99.1
LLY
Lilly(Eli) & Co
30 Apr 24
Lilly Reports First-Quarter 2024 Financial Results and Raises Full-Year Revenue Guidance by $2 Billion, Highlights Pipeline Momentum
7:04am
life better for millions more people. That includes delivering innovative clinical trials that reflect the diversity of our world and working to ensure
PX14A6G
As You Sow
11 Apr 24
Letter to shareholders
12:59pm
, has also been shown to encourage more creative and innovative workplace environments.11
By contrast, if the lack of diversity at a company is a result
PX14A6G
Trinity Health Corp
28 Mar 24
Letter to shareholders
12:20pm
, which receives innovative and improved medicines, as well as timely access to generic drugs.6
We believe that balance is now out of whack. Given … , reliance on patent thickets may actually diminish branded drug manufacturers’ incentives to continue developing innovative medicines
424B2
q9t2f30ck5uez7soa
8 Feb 24
Prospectus for primary offering
4:51pm
424B2
sa54vj756tf5o7rmon
7 Feb 24
Prospectus for primary offering
8:12am
8-K
EX-99.1
9encyxbtq6x5 lk8
6 Feb 24
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance
7:04am
SC TO-T/A
EX-99
zzhn2t2jncds w88
18 Dec 23
Third party tender offer statement (amended)
6:59am
SC TO-T/A
EX-99
tywxr6p2tw0ey p8yn0g
4 Dec 23
Third party tender offer statement (amended)
7:04am
SC TO-T/A
EX-99
ifmi2r
17 Nov 23
Third party tender offer statement (amended)
6:53am
SC TO-T/A
EX-99
wa7ljcyspyf6n kt
15 Nov 23
Third party tender offer statement (amended)
6:51am
SC TO-T/A
EX-99
396zmtrn rvpmh6uiuj5
8 Nov 23
Third party tender offer statement (amended)
5:06pm
8-K
EX-99.1
47zjzwqslvhmxj
2 Nov 23
Lilly Reports Third-Quarter 2023 Financial Results, Highlights Strong Sales Growth and Business Development Activity
7:02am
CORRESP
83nux3wc
26 Oct 23
Correspondence with SEC
12:00am
SC TO-C
EX-99.1
f5noupo m2m0vjqp
3 Oct 23
Information about tender offer
4:30pm
CORRESP
r3aqp63fty4k
20 Sep 23
Correspondence with SEC
12:00am